Akebia Therapeutics Reports Fourth Quarter And Full Year 2024 Financial Results And Vafseo® (Vadadustat) Commercial Launch Progress Update
Strong results to date of Vafseo U.S. launch; expect Vafseo Q1 2025 net product revenues of approximately $10-$11 million Cash resources an ...